big pharma hasn’t taken a bite yet so there must be some decent risks in ph3 result - dropping $500M is nothing for big pharma vs potential sales of few $B per year
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Completes Enrollment in Phase 3 Clinical Program
Ann: Opthea Completes Enrollment in Phase 3 Clinical Program, page-19
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
59.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $735.5M |
Open | High | Low | Value | Volume |
59.0¢ | 60.3¢ | 58.5¢ | $374.2K | 626.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 72322 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.5¢ | 65222 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 62653 | 0.590 |
13 | 53979 | 0.585 |
15 | 130910 | 0.580 |
10 | 148805 | 0.575 |
3 | 46261 | 0.570 |
Price($) | Vol. | No. |
---|---|---|
0.595 | 18367 | 8 |
0.600 | 33304 | 19 |
0.605 | 22605 | 8 |
0.610 | 46916 | 8 |
0.615 | 90862 | 7 |
Last trade - 12.22pm 12/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |